Pharmacokinetic Study and Metabolite Identification of CAM106 in Rats by Validated UHPLC-MS/MS

• Главные авторы: Ruqi Xi (Автор), Rahima Abdulla (Автор), Jiangyu Zhao (Автор), Haji Akber Aisa (Автор), Yongqiang Liu (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2023-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Given the limitations of existing antiviral drugs and vaccines, there is still an urgent need for new anti-influenza drugs. CAM106, a rupestonic acid derivative, was studied for its potent antiviral activity and showed a favorable inhibitory effect on influenza virus replication. However, many gaps...